Cost-effectiveness of multidisciplinary care in mild to moderate chronic kidney disease in the United States: A modeling study.

Eugene Lin Glenn M Chertow Brandon W YanElizabeth MalcolmJeremy D Goldhaber-Fiebert

Published in: PLoS medicine (2018)

Our model estimates that a Medicare-funded MDC program could reduce the need for dialysis, prolong life expectancy, and meet conventional cost-effectiveness thresholds in middle-aged to elderly patients with mild to moderate CKD.

Keyphrases

chronic kidney disease
middle aged
end stage renal disease
quality improvement
healthcare
palliative care
peritoneal dialysis
community dwelling
chronic pain
health insurance